Fear of cancer may have unwanted effect on public screening uptake
the ONA take:
People who worry about developing cancer are more likely to want to undergo screening for colon cancer; however, according to new research from the Cancer Research UK Health Behaviour Research Centre at UCL, that fear makes them less likely to actually go for the test.
Research to date has used a combined measure of cancer fear, which does not explain how fear results in such different actions. In this study, the researchers distinguished different aspects of fear to see whether it had different effects on people’s decisions about cancer screening.
Approximately 2,000 participants were randomized to receive a screening invitation. Clinical records show that 71% actually attended; 68% of those who reported feeling uncomfortable thinking about cancer attended screening, compared with 77% of those who did not feel uncomfortable.
The research findings suggest that public service announcements about colon cancer screening need to focus more on the preventive value of screening than increasing public fear of cancer.
People who worry about developing cancer are more likely to want to undergo screening for colon cancer.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Adherence to Tamoxifen, AIs Among Older Women is Low, Study Shows
- Replacing Neoadjuvant CRT with Multiagent Chemo Not Recommended for Rectal Cancer
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|